These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 21044444)
1. Use of methotrexate in undifferentiated arthritis. Visser K; Allaart CF; Huizinga TW Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S117-21. PubMed ID: 21044444 [TBL] [Abstract][Full Text] [Related]
2. Brief Report: Clinical Trials Aiming to Prevent Rheumatoid Arthritis Cannot Detect Prevention Without Adequate Risk Stratification: A Trial of Methotrexate Versus Placebo in Undifferentiated Arthritis as an Example. Burgers LE; Allaart CF; Huizinga TWJ; van der Helm-van Mil AHM Arthritis Rheumatol; 2017 May; 69(5):926-931. PubMed ID: 28217975 [TBL] [Abstract][Full Text] [Related]
3. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. van der Helm-van Mil AH; le Cessie S; van Dongen H; Breedveld FC; Toes RE; Huizinga TW Arthritis Rheum; 2007 Feb; 56(2):433-40. PubMed ID: 17265478 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. van Dongen H; van Aken J; Lard LR; Visser K; Ronday HK; Hulsmans HM; Speyer I; Westedt ML; Peeters AJ; Allaart CF; Toes RE; Breedveld FC; Huizinga TW Arthritis Rheum; 2007 May; 56(5):1424-32. PubMed ID: 17469099 [TBL] [Abstract][Full Text] [Related]
5. Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study. van Aken J; van Dongen H; le Cessie S; Allaart CF; Breedveld FC; Huizinga TW Ann Rheum Dis; 2006 Jan; 65(1):20-5. PubMed ID: 15901632 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice. Punzi L; Lapadula G; Mathieu A BioDrugs; 2014 Apr; 28 Suppl 1():S25-37. PubMed ID: 24687236 [TBL] [Abstract][Full Text] [Related]
8. Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study). van Aken J; Heimans L; Gillet-van Dongen H; Visser K; Ronday HK; Speyer I; Peeters AJ; Huizinga TW; Allaart CF Ann Rheum Dis; 2014 Feb; 73(2):396-400. PubMed ID: 23334213 [TBL] [Abstract][Full Text] [Related]
9. Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study). Heimans L; Akdemir G; Boer KV; Goekoop-Ruiterman YP; Molenaar ET; van Groenendael JH; Peeters AJ; Steup-Beekman GM; Lard LR; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF Arthritis Res Ther; 2016 Jan; 18():23. PubMed ID: 26794605 [TBL] [Abstract][Full Text] [Related]
10. Preventing the progression from undifferentiated arthritis to rheumatoid arthritis: the clinical and economic implications. Schiff MH Am J Manag Care; 2010 Nov; 16(9 Suppl):S243-8. PubMed ID: 21517637 [TBL] [Abstract][Full Text] [Related]
11. Folate supplementation during methotrexate therapy for rheumatoid arthritis. Morgan SL; Baggott JE Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S102-9. PubMed ID: 21044441 [TBL] [Abstract][Full Text] [Related]
12. Modern treatment strategies in rheumatoid arthritis. Hetland ML Dan Med Bull; 2011 Nov; 58(11):B4320. PubMed ID: 22047935 [TBL] [Abstract][Full Text] [Related]
13. Clinical, functional, and radiographic benefits of longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis. Keystone EC; van der Heijde D; Kavanaugh A; Kupper H; Liu S; Guérette B; Mozaffarian N J Rheumatol; 2013 Sep; 40(9):1487-97. PubMed ID: 23818718 [TBL] [Abstract][Full Text] [Related]
14. Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making. van der Helm-van Mil AH; Detert J; le Cessie S; Filer A; Bastian H; Burmester GR; Huizinga TW; Raza K Arthritis Rheum; 2008 Aug; 58(8):2241-7. PubMed ID: 18668546 [TBL] [Abstract][Full Text] [Related]
15. Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study). Wevers-de Boer K; Visser K; Heimans L; Ronday HK; Molenaar E; Groenendael JH; Peeters AJ; Westedt ML; Collée G; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF Ann Rheum Dis; 2012 Sep; 71(9):1472-7. PubMed ID: 22402145 [TBL] [Abstract][Full Text] [Related]
16. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort. Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185 [TBL] [Abstract][Full Text] [Related]
17. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. van der Heijde D; Klareskog L; Landewé R; Bruyn GA; Cantagrel A; Durez P; Herrero-Beaumont G; Molad Y; Codreanu C; Valentini G; Zahora R; Pedersen R; MacPeek D; Wajdula J; Fatenejad S Arthritis Rheum; 2007 Dec; 56(12):3928-39. PubMed ID: 18050208 [TBL] [Abstract][Full Text] [Related]